// App-Quantinova.ai

: Studying Methylation Status of Protein Tyrosine Phosphatase Receptor Gamma (PTPRG) in Chronic Myeloid Leukemia Patients in the State of Qatar

Researchers

Presenter

  • Mohamed Ismail

Principal Investigators

  • Marzia Vezzalini

  • Ali Al Sayab

  • Maria Monne

  • Vinod Gupta

  • Govundarajulu Varadharaj

  • Mohamed Alsharshani

  • Mohamed Yassin

  • Claudio Sorio

  • Helmout Modjtahedi

  • Nader I. Al-Dewik

Medical Centers

  • Department of Medicine, University of Verona, Strada le Grazie 8, 37134 Verona, Italy, Verona, Italy

  • Interim Translational Research Institute (iTRI), Hamad Medical Corporation., Doha, Qatar

  • Centro di Diagnostica Biomolecolare e Citogenetica Emato-Oncologica, "San Francesco" Hospital., Nuoro, Italy

  • Genetrics Inc, Hyderabad, India

  • Hammad medical coroprtaion, Doha, Qatar

  • National Center for Cancer Care & Research, Hamad Medical Corporation, Doha, Qatar

  • University of Verona, Verona, Italy

  • School of Life Science, Pharmacy and Chemistry, faculty of science, engineering & computing-Kingston University London, London, United Kingdom

  • Qatar Medical Genetic Center, Hamad Medical city, building no 21 HGH, Doha, Qatar

Locations

  • Qatar

  • Italy

  • India

  • United Kingdom

Companies

  • Hamad Medical Corpor

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Nucleoside diphosphate kinase A

  • Protein Tyrosine Phosphatase, Receptor Type G

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved